Cannabis Science Conference Spring Heads to Kansas City, Missouri in 2024 Along with New Compliance Track
Cannabis Science Conference Spring 2024 will take place May 7-9, 2024 in Kansas City, Missouri and feature four dedicated tracks–analytical science, medical cannabis, cultivation, and compliance.
Cannabis Science Conference (CSC), the premier cannabis science conference event focusing on analytical science, medical cannabis, and cultivation, announced today the addition of a new track focused on compliance. The track will be chaired by Kim Stuck, founder and CEO of Allay Consulting, a compliance strategy and services provider serving the hemp and cannabis industries nationwide.
Kim Stuck, founder and CEO of Allay Consulting.
Stuck’s background on compliance makes her uniquely qualified to run this new track. She brings a regulator’s keen eye and wide-reaching knowledge on evolving compliance and safety mandates to support businesses in tightly regulated industries. Previously, Ms. Stuck held a pioneering role as the nation’s first cannabis and hemp specialist for a major metropolitan public health authority. During her tenure with the City of Denver, home to hundreds of cannabis businesses, she worked as an investigator covering cultivation, manufacturing, and retail. Her duties included facility inspections; conducting investigations into improper pesticide use and worker safety; creating regulations; instituting recalls; and public outreach. In addition to serving on several industry advisory boards, she has been a member of ASTM International’s cannabis standards committee since its 2017 inception. Stuck is also a regular writer for Cannabis Science and Technology under the “Stuck on Compliance” blog.
“Kim Stuck was a natural choice for this track and we are thrilled to have her on board,” said Meg L’Heureux, spokesperson for CSC, and the group editorial director of Cannabis Science and Technology and Cannabis Patient Care magazines. “Kansas City is in a great position as an emerging market in the cannabis space, but with that comes the need for education and lessons from experienced professionals—that’s what our conference brings to the table and what sets it apart from the rest!”
CSC is also excited to announce that several program chairs from 2023 will be returning for the 2024 events: Analytical chair Dr. Julie Kowalski, a technical consultant serving the cannabis and hemp testing markets; Cultivation chair Dr. Zacariah L. Hildenbrand, who sits on the Editorial Advisory Board of Cannabis Science and Technology; and Medical chair Cherissa Jackson, who served 23 years of active-duty military service with 10 years as a US Air Force Nurse.
The conference is accepting abstract submissions for both oral and poster submissions through January 10, 2024. Please visit the CSC website for regular updates.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.
